Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Circulating PCSK9 as a prognostic biomarker of cardiovascular events in individuals with type 2 diabetes: evidence from a 16.8-year follow-up study

Fig. 1

Assessment of circulating levels of PCSK9. A Distribution plot of serum PCSK9 concentrations in patients with T2DM. B Marginal means plot of serum PCSK9 in patients with T2DM grouped according to sex and presence of complications. ***p < 0.001 for Tukey’s post-hoc tests following two-way ANOVA. PCSK9 proprotein convertase subtilisin/kexin type 9, T2DM type 2 diabetes mellitus

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840